The likelihood of having a serum PSA level of >= 2.5 or >= 4.0 ng ml(-1) according to obesity in a screened Korean population
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Won Jae | - |
dc.date.accessioned | 2021-08-12T00:44:49Z | - |
dc.date.available | 2021-08-12T00:44:49Z | - |
dc.date.issued | 2013-11 | - |
dc.identifier.issn | 1008-682X | - |
dc.identifier.issn | 1745-7262 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13259 | - |
dc.description.abstract | This study aimed to determine if lower serum total prostate-specific antigen (PSA) levels in obese Korean men affect prostate cancer (PCa) screening, as an increased body mass index (BMI) is inversely associated with the PSA level. Between March 2007 and December 2012, 22 208 native Korean men who were eligible to receive a serum PSA test were recruited. Logistic regression was used to estimate the odds of an 'abnormal' PSA (>= 2.5 or >= 4.0 ng ml(-1)) in these men (age: 45-75 years, PSA, 10 ng ml(-1)) based on BMI, which was categorized as normal (BMI >= 25 kg m(-2)) and obese (BMI >= 25 kg m 22). In all, 20 509 men (92.3%) were included in the study after applying the inclusion criteria. After controlling for age, there was a statistically significant trend towards a lower likelihood of having a serum PSA level >= 2.5 ng ml(-1) with an increased BMI, with obese men having an 18% lower likelihood (odds ratio: 0.823, 95% confidence interval: 0.743-0.912; P<0.001) compared to men with a normal BMI. Obese men were approximately 82% as likely to have a PSA level >= 2.5 ng ml(-1) as men with a normal BMI. These results might affect PCa screening using serum total PSA. Further studies are needed to better define these results in clinical biopsy practice. | - |
dc.format.extent | 3 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Shanghai Institute of Materia Medica | - |
dc.title | The likelihood of having a serum PSA level of >= 2.5 or >= 4.0 ng ml(-1) according to obesity in a screened Korean population | - |
dc.type | Article | - |
dc.publisher.location | 인도 | - |
dc.identifier.doi | 10.1038/aja.2013.77 | - |
dc.identifier.scopusid | 2-s2.0-84887242982 | - |
dc.identifier.wosid | 000326878200019 | - |
dc.identifier.bibliographicCitation | Asian Journal of Andrology, v.15, no.6, pp 770 - 772 | - |
dc.citation.title | Asian Journal of Andrology | - |
dc.citation.volume | 15 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 770 | - |
dc.citation.endPage | 772 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Andrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | PROSTATE-SPECIFIC ANTIGEN | - |
dc.subject.keywordPlus | BODY-MASS INDEX | - |
dc.subject.keywordPlus | CANCER DETECTION | - |
dc.subject.keywordPlus | WEIGHT CHANGE | - |
dc.subject.keywordPlus | 10.0 NG/ML | - |
dc.subject.keywordPlus | MEN | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | COHORT | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | ASIA | - |
dc.subject.keywordAuthor | obesity | - |
dc.subject.keywordAuthor | prostate cancer (PCa) | - |
dc.subject.keywordAuthor | prostate-specific antigen (PSA) | - |
dc.subject.keywordAuthor | screening | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.